Jeffrey B. Kindler, Director of Praxis Precision Medicines PRAX, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $854.7K. The latest trade was on 06/10.

JK

JK

Jeffrey B. Kindler

Director

Company

Praxis Precision Medicines PRAX

First filing

23/03/13

Trades

57 trades

Buys / sales

0 / 5

12-month net buying

−$854.7K

Last trade

06/10

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
PrecigenPGEN	Open-market sale	25/12/12	25/12/16	235,467 sh	$3.63	$854,745.21	−68.0%
PrecigenPGEN	Open-market sale	25/09/29–25/09/30	25/10/01	174,360 sh2 trades	$3.47avg.	$604,191.86	−33.5%
PerrigoPRGO	Open-market sale10b5-1 plan	24/12/09	24/12/10	17,598 sh	$28.27	$497,495.46	−76.5%
PrecigenPGEN	Open-market sale	23/12/28	23/12/29	96,686 sh	$1.41	$136,327.26	−28.9%